Xencor (XNCR) Financials

Xencor logo
$34.50 -0.90 (-2.54%)
Closing price 04:00 PM Eastern
Extended Trading
$34.49 -0.01 (-0.01%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Xencor

Annual Income Statements for Xencor

This table shows Xencor's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-18 45 -39 -70 29 -70 83 -55 -133 -233 -92
Consolidated Net Income / (Loss)
-18 45 -38 -70 27 -69 83 -55 -133 -237 -92
Net Income / (Loss) Continuing Operations
-18 45 -38 -70 27 -69 83 -55 -133 -237 -92
Total Pre-Tax Income
-18 46 -39 -70 27 -69 83 -55 -120 -235 -90
Total Operating Income
-18 44 -43 -79 14 -77 44 -82 -132 -178 -178
Total Gross Profit
28 109 46 41 157 123 275 165 175 110 126
Total Revenue
28 109 46 41 157 123 275 165 175 110 126
Operating Revenue
28 109 46 41 157 123 275 165 175 110 126
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
46 65 89 120 143 199 231 247 307 289 303
Selling, General & Admin Expense
12 13 18 22 24 30 39 47 53 61 64
Research & Development Expense
34 52 72 98 119 170 193 200 254 228 239
Total Other Income / (Expense), net
0.75 2.08 4.17 8.96 13 7.46 39 28 13 -57 88
Interest Expense
0.01 0.02 -4.18 -9.09 -14 -7.26 0.01 -4.82 6.18 37 32
Interest & Investment Income
0.74 2.09 - - - - 0.86 - 19 32 28
Other Income / (Expense), net
0.02 0.01 -0.01 -0.13 -0.26 0.20 38 23 -0.43 -52 92
Income Tax Expense
- 0.99 -0.46 0.00 0.31 0.00 0.00 0.67 14 1.62 2.50
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - - - 0.00 0.00 -0.16 -3.92 -0.21
Basic Earnings per Share
($0.45) $1.09 ($0.82) ($1.31) $0.48 ($1.21) $1.42 ($0.93) ($2.20) ($3.58) ($1.24)
Weighted Average Basic Shares Outstanding
39.02M 41.27M 46.82M 53.94M 56.53M 57.21M 58.38M 59.65M 60.50M 65.04M 74.24M
Diluted Earnings per Share
($0.45) $1.07 ($0.82) ($1.31) $0.46 ($1.21) $1.37 ($0.93) ($2.20) ($3.58) ($1.24)
Weighted Average Diluted Shares Outstanding
39.02M 42.39M 46.82M 53.94M 58.47M 57.21M 60.50M 59.65M 60.50M 65.04M 74.24M
Weighted Average Basic & Diluted Shares Outstanding
39.10M 41.40M -167.30M 53.70M 56.94M 57.95M 59.38M 60.03M 61.12M 70.46M 73.34M

Quarterly Income Statements for Xencor

This table shows Xencor's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-73 -67 -46 -46 -48 -31 -6.03 -6.65 -129 -22 39
Consolidated Net Income / (Loss)
-74 -69 -47 -46 -49 -31 -6.03 -6.65 -129 -22 39
Net Income / (Loss) Continuing Operations
-74 -69 -47 -46 -49 -31 -6.03 -6.65 -129 -22 39
Total Pre-Tax Income
-74 -69 -47 -45 -48 -31 -6.03 -4.27 -129 -22 39
Total Operating Income
-55 -55 -55 -13 -43 -33 -48 -54 -78 -37 23
Total Gross Profit
16 24 18 53 33 44 21 28 4.52 51 117
Total Revenue
16 24 18 53 33 44 21 28 4.52 51 117
Operating Revenue
16 24 18 53 33 44 21 28 4.52 51 117
Total Cost of Revenue
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Operating Expenses
71 79 73 66 76 77 69 82 82 88 94
Selling, General & Admin Expense
14 18 15 15 17 15 14 17 18 16 9.36
Research & Development Expense
57 62 58 51 59 62 54 65 65 72 84
Total Other Income / (Expense), net
-19 -13 7.76 -31 -5.08 2.10 41 49 -51 15 16
Interest Expense
9.68 9.28 9.03 -23 8.67 8.24 7.67 7.35 4.70 7.35 4.11
Interest & Investment Income
8.55 7.68 7.54 - 7.54 7.25 6.54 6.20 5.46 4.80 4.90
Other Income / (Expense), net
-18 -12 9.24 -31 -3.96 3.09 43 51 -52 18 16
Income Tax Expense
0.00 0.00 0.00 - 0.37 -0.25 0.00 2.39 0.28 -0.19 -0.18
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.68 -1.45 -1.15 -0.65 -0.21 0.00 0.00 - 0.00 0.00 0.00
Basic Earnings per Share
($1.20) ($1.09) ($0.72) ($0.57) ($0.66) ($0.41) ($0.08) ($0.09) ($1.71) ($0.29) $0.52
Weighted Average Basic Shares Outstanding
61.21M 61.68M 64.02M 65.04M 73.67M 74.28M 74.41M 74.24M 75.25M 75.86M 76.22M
Diluted Earnings per Share
($1.20) ($1.09) ($0.72) ($0.57) ($0.66) ($0.41) ($0.08) ($0.09) ($1.71) ($0.29) $0.50
Weighted Average Diluted Shares Outstanding
61.21M 61.68M 64.02M 65.04M 73.67M 74.28M 74.41M 74.24M 75.25M 75.86M 78.35M
Weighted Average Basic & Diluted Shares Outstanding
61.66M 61.83M 69.98M 70.46M 71.17M 71.32M 71.41M 73.34M 74.14M 74.35M 75.04M

Annual Cash Flow Statements for Xencor

This table details how cash moves in and out of Xencor's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-42 1.94 2.00 9.72 24 113 -20 -90 0.23 -13 13
Net Cash From Operating Activities
27 95 -34 -80 64 -5.00 -17 24 -78 -202 -135
Net Cash From Continuing Operating Activities
27 95 -34 -80 64 -5.00 -17 24 -78 -202 -135
Net Income / (Loss) Continuing Operations
-18 45 -38 -70 27 -69 83 -55 -133 -237 -92
Consolidated Net Income / (Loss)
-18 45 -38 -70 27 -69 83 -55 -133 -237 -92
Depreciation Expense
1.11 1.47 2.03 3.25 4.30 5.79 7.49 8.80 11 12 11
Amortization Expense
1.10 2.04 2.85 -0.39 -4.32 -0.27 3.16 0.13 -14 -16 -3.48
Non-Cash Adjustments To Reconcile Net Income
4.25 7.59 14 20 33 9.23 -48 82 40 77 -94
Changes in Operating Assets and Liabilities, net
38 39 -14 -33 4.48 50 -62 -11 17 -39 44
Net Cash From Investing Activities
-185 -214 32 -165 -51 100 -46 -120 -111 -7.87 140
Net Cash From Continuing Investing Activities
-185 -214 32 -165 -51 100 -46 -120 -111 -7.87 140
Purchase of Property, Plant & Equipment
-1.93 -1.51 -5.31 -7.21 -7.35 -11 -13 -38 -18 -6.10 -3.15
Acquisitions
-1.75 -1.50 -1.97 -1.94 -3.69 -3.23 -2.68 -4.91 -2.80 -3.42 0.00
Purchase of Investments
-216 -317 -77 -378 -497 -644 -510 -388 -783 -595 -299
Sale of Property, Plant & Equipment
0.01 - - 0.01 0.00 0.00 0.02 0.00 0.00 0.00 0.00
Sale and/or Maturity of Investments
34 106 116 222 457 758 485 307 693 597 442
Net Cash From Financing Activities
116 121 3.73 254 11 18 43 5.70 189 197 8.23
Net Cash From Continuing Financing Activities
116 121 3.73 254 11 18 43 5.70 189 197 8.23
Repurchase of Common Equity
-7.70 -7.28 - -15 - - - 0.00 0.00 -12 0.00
Issuance of Common Equity
124 128 3.73 269 11 18 43 5.70 5.89 209 9.96
Other Financing Activities, net
- - - - - - 0.00 0.00 183 0.00 -1.73
Cash Interest Paid
0.01 0.02 0.01 0.02 0.01 0.02 0.01 0.01 0.02 0.03 0.01
Cash Income Taxes Paid
0.00 0.94 0.97 0.23 0.40 0.00 0.00 0.70 0.00 6.10 7.31

Quarterly Cash Flow Statements for Xencor

This table details how cash moves in and out of Xencor's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-23 -0.26 -1.74 12 -1.30 4.77 -16 26 -40 21 15
Net Cash From Operating Activities
-57 -69 -32 -50 -16 -36 -31 -52 -68 -56 2.64
Net Cash From Continuing Operating Activities
-57 -69 -32 -50 -16 -36 -31 -52 -68 -65 -2.23
Net Income / (Loss) Continuing Operations
-74 -74 -54 -46 -49 -31 -6.03 -6.65 -129 -22 39
Consolidated Net Income / (Loss)
-74 -74 -54 -46 -49 -31 -6.03 -6.65 -129 -22 39
Depreciation Expense
3.04 3.02 3.05 2.99 2.69 2.65 2.59 2.58 2.57 2.44 2.24
Amortization Expense
-6.91 -4.44 -3.47 -2.54 -2.13 0.64 -1.65 -0.34 -0.13 -0.01 0.05
Non-Cash Adjustments To Reconcile Net Income
27 4.50 -9.19 3.93 6.74 -25 -11 -88 61 -24 -15
Changes in Operating Assets and Liabilities, net
-6.00 2.15 32 -8.03 25 17 -14 41 -2.34 -22 -29
Net Cash From Investing Activities
32 66 -163 57 14 40 15 71 27 85 7.33
Net Cash From Continuing Investing Activities
32 66 -163 57 14 40 15 71 27 85 7.33
Purchase of Property, Plant & Equipment
-0.13 -3.03 -1.28 -1.66 -1.44 -0.38 -0.18 -1.14 -0.61 -0.54 -1.80
Purchase of Investments
-137 -123 -282 -54 -104 -73 -84 -38 -73 - -145
Sale and/or Maturity of Investments
170 192 120 114 119 114 99 110 100 86 154
Net Cash From Financing Activities
1.79 2.67 193 4.43 1.25 0.66 - 6.32 0.95 1.03 9.99
Net Cash From Continuing Financing Activities
1.79 2.67 193 4.43 1.25 0.66 - 6.32 0.95 1.03 9.99
Issuance of Common Equity
1.79 1.07 202 4.43 2.97 0.66 - 6.32 0.95 1.03 9.99
Cash Interest Paid
0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.00
Cash Income Taxes Paid
- 6.10 - - 0.00 - 0.36 -0.05 3.01 1.12 -1.84

Annual Balance Sheets for Xencor

This table presents Xencor's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
207 429 390 577 670 703 538 846 965 952 875
Total Current Assets
98 142 231 316 558 638 424 675 636 578 600
Cash & Equivalents
13 15 17 26 50 164 143 54 54 41 54
Short-Term Investments
84 116 208 268 479 439 191 569 540 457 494
Accounts Receivable
0.04 8.62 1.14 10 22 11 66 29 24 61 29
Prepaid Expenses
1.20 2.90 5.61 10 6.55 11 24 23 18 19 23
Plant, Property, & Equipment, net
2.31 3.11 7.09 12 16 22 28 59 66 60 53
Total Noncurrent Assets
107 284 152 249 96 44 85 112 263 315 222
Long-Term Investments
97 273 139 236 72 1.03 - 3.83 210 257 176
Intangible Assets
9.97 10 11 12 14 16 16 19 19 18 8.39
Other Noncurrent Operating Assets
0.06 0.10 0.28 0.31 9.69 27 64 89 35 39 38
Other Noncurrent Nonoperating Assets
- - - - - - - - - - 0.29
Total Liabilities & Shareholders' Equity
207 429 390 577 670 703 838 846 965 952 875
Total Liabilities
44 115 74 55 77 131 105 119 303 278 240
Total Current Liabilities
43 106 73 54 67 121 71 64 74 87 96
Short-Term Debt
- - - - - - - 0.00 28 48 43
Accounts Payable
6.40 3.88 6.87 3.80 10 8.95 14 10 14 17 11
Accrued Expenses
3.63 6.69 5.48 9.66 9.00 18 19 19 24 19 35
Current Deferred & Payable Income Tax Liabilities
- 0.07 0.16 - - - - 0.00 5.29 0.00 3.59
Other Current Liabilities
- - - 0.00 2.17 1.89 0.00 4.71 3.44 3.01 3.26
Total Noncurrent Liabilities
1.05 8.32 1.09 1.20 10 9.74 34 55 229 190 144
Long-Term Debt
- - - - - - - 0.00 162 115 76
Noncurrent Deferred Revenue
1.05 8.32 1.09 1.20 1.93 - - - - 9.99 2.78
Other Noncurrent Operating Liabilities
- - - 0.00 8.57 9.74 34 55 67 65 65
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
162 314 316 522 593 572 734 727 662 674 636
Total Preferred & Common Equity
162 314 316 522 593 572 734 727 662 678 636
Total Common Equity
162 314 316 522 593 572 734 727 662 678 636
Common Stock
425 553 571 846 888 938 1,018 1,073 1,132 1,382 1,430
Retained Earnings
-262 -238 -253 -323 -296 -366 -283 -338 -471 -704 -796
Accumulated Other Comprehensive Income / (Loss)
-0.52 -1.44 -1.81 -0.97 1.16 0.07 -1.51 -6.95 1.29 -0.66 1.58
Noncontrolling Interest
- - - - - - - 0.00 0.34 -3.59 0.00

Quarterly Balance Sheets for Xencor

This table presents Xencor's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
778 778 897 841 1,000 905 879 869 737 725 771
Total Current Assets
594 571 575 569 590 521 513 518 483 523 499
Cash & Equivalents
35 53 31 31 29 40 44 28 14 45 60
Short-Term Investments
517 442 505 478 514 430 399 443 431 412 345
Accounts Receivable
20 55 22 36 26 38 48 22 12 42 65
Prepaid Expenses
22 22 17 25 21 14 22 26 26 25 29
Plant, Property, & Equipment, net
68 68 64 64 62 59 57 55 51 50 50
Total Noncurrent Assets
117 139 258 208 348 325 309 296 202 152 222
Long-Term Investments
64 85 199 149 290 273 260 247 157 109 178
Intangible Assets
19 19 19 19 18 13 11 9.47 7.60 6.52 5.05
Other Noncurrent Operating Assets
34 36 41 40 40 38 38 39 38 37 36
Other Noncurrent Nonoperating Assets
- - - - - - - - - - 3.19
Total Liabilities & Shareholders' Equity
778 778 897 841 1,000 905 879 869 737 725 771
Total Liabilities
99 109 297 292 294 265 259 243 221 222 210
Total Current Liabilities
45 53 71 76 91 88 96 86 73 82 76
Short-Term Debt
- - 34 39 44 53 50 45 26 27 23
Accounts Payable
14 15 16 16 19 16 19 9.08 7.92 13 6.65
Accrued Expenses
18 24 13 20 25 16 24 28 34 36 41
Current Deferred & Payable Income Tax Liabilities
- - 5.29 0.00 0.00 - - - 0.84 1.50 1.15
Other Current Liabilities
4.23 4.38 2.08 1.26 2.18 3.64 3.38 3.94 4.03 3.92 4.33
Total Noncurrent Liabilities
55 56 226 216 203 176 163 157 148 140 134
Long-Term Debt
- - 151 141 128 102 95 88 82 78 72
Noncurrent Deferred Revenue
- - 0.00 - - - - - 2.88 0.88 0.88
Other Noncurrent Operating Liabilities
55 56 75 75 75 75 68 69 63 61 61
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
679 669 600 549 706 640 620 625 516 503 560
Total Preferred & Common Equity
679 669 600 550 709 640 620 625 516 503 560
Total Common Equity
679 669 600 550 709 640 620 625 516 503 560
Common Stock
1,102 1,115 1,145 1,163 1,366 1,392 1,403 1,413 1,440 1,451 1,470
Retained Earnings
-421 -445 -545 -612 -658 -752 -783 -789 -925 -947 -907
Accumulated Other Comprehensive Income / (Loss)
-1.86 -0.71 -0.15 -0.65 1.80 0.36 0.26 1.16 0.03 -0.87 -2.53
Noncontrolling Interest
- - -0.34 -1.78 -2.94 0.00 0.00 0.00 0.00 0.00 0.00

Annual Metrics And Ratios for Xencor

This table displays calculated financial ratios and metrics derived from Xencor's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
40,477,003.00 41,138,851.00 46,960,847.00 56,234,332.00 56,721,172.00 57,455,204.00 58,481,559.00 - - - 71,410,469.00
DEI Adjusted Shares Outstanding
40,477,003.00 41,138,851.00 46,960,847.00 56,234,332.00 56,721,172.00 57,455,204.00 58,481,559.00 - - - 71,410,469.00
DEI Earnings Per Adjusted Shares Outstanding
-0.43 1.10 -0.83 -1.24 0.51 -1.23 1.41 - - - -1.29
Growth Metrics
- - - - - - - - - - -
Revenue Growth
191.62% 292.70% -57.62% -12.11% 285.93% -21.70% 124.23% -40.18% 6.10% -36.72% 13.65%
EBITDA Growth
-3.53% 395.08% -180.45% -100.33% 117.67% -624.73% 230.05% -154.52% -167.71% -73.54% 66.60%
EBIT Growth
-11.41% 340.39% -197.92% -84.31% 117.07% -664.54% 206.77% -172.54% -123.83% -73.37% 62.98%
NOPAT Growth
-11.43% 435.71% -170.05% -84.05% 124.60% -493.39% 181.42% -231.91% -60.49% -34.79% 0.51%
Net Income Growth
-7.12% 356.51% -185.29% -82.95% 138.17% -357.98% 219.18% -166.78% -141.56% -77.45% 61.05%
EPS Growth
13.46% 337.78% -176.64% -59.76% 135.11% -363.04% 213.22% -167.88% -136.56% -62.73% 65.36%
Operating Cash Flow Growth
224.89% 257.15% -135.28% -137.39% 180.71% -107.77% -236.79% 245.29% -418.26% -159.46% 33.17%
Free Cash Flow Firm Growth
210.20% 348.27% -171.61% -28.54% 113.87% -333.17% -186.54% 31.52% 32.38% -297.79% 54.17%
Invested Capital Growth
-765.57% -189.82% 47.65% 81.25% 7.75% -289.65% 413.19% 1.69% -52.17% 72.52% -61.46%
Revenue Q/Q Growth
137.85% 6.02% 5.14% -31.41% -4.91% 45.45% 68.83% -44.58% 20.21% 19.78% -16.36%
EBITDA Q/Q Growth
38.25% 10.06% -18.43% -55.71% -41.98% 20.40% 1,799.57% -232.10% -2.41% -4.88% 33.63%
EBIT Q/Q Growth
32.45% 10.10% -16.64% -50.10% -41.47% 17.47% 1,617.01% -312.11% 0.30% -6.25% 32.47%
NOPAT Q/Q Growth
32.40% 7.72% -16.62% -49.86% -41.39% 18.01% 201.53% -211.51% 10.33% 14.64% -29.51%
Net Income Q/Q Growth
34.11% 11.57% -15.17% -57.00% -24.49% 16.02% 2,105.12% -284.42% -11.99% -16.62% 30.03%
EPS Q/Q Growth
35.71% 9.18% -20.59% -50.57% -28.13% 15.38% 1,470.00% -286.00% -10.55% -12.23% 27.91%
Operating Cash Flow Q/Q Growth
8.19% -10.63% 20.19% -14.52% -4.16% 87.99% 72.62% -77.88% 35.35% -800.70% -1.41%
Free Cash Flow Firm Q/Q Growth
-5.68% 6.86% -69.90% 9.95% -27.88% 50.66% 22.17% -338.16% 64.27% -56.78% 19.28%
Invested Capital Q/Q Growth
30.21% 9.99% 43.17% 43.51% 20.88% -118.62% 83.49% 24.60% -46.44% 82.59% -20.50%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-58.04% 43.61% -82.80% -188.75% 8.64% -57.93% 33.60% -30.62% -77.27% -211.91% -62.27%
Operating Margin
-66.05% 40.40% -93.34% -195.48% 8.82% -62.59% 15.91% -50.11% -75.80% -161.47% -141.35%
EBIT Margin
-66.00% 40.40% -93.36% -195.79% 8.66% -62.43% 29.73% -36.05% -76.05% -208.35% -67.87%
Profit (Net Income) Margin
-63.37% 41.39% -83.30% -173.41% 17.15% -56.51% 30.04% -33.53% -76.34% -214.08% -73.37%
Tax Burden Percent
100.00% 97.85% 98.81% 100.00% 98.85% 100.00% 100.00% 101.23% 111.42% 100.69% 102.79%
Interest Burden Percent
96.01% 104.70% 90.31% 88.57% 200.38% 90.52% 101.04% 91.88% 90.09% 102.05% 105.17%
Effective Tax Rate
0.00% 2.15% 0.00% 0.00% 1.15% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 129.98% -57.86% -124.59% -190.45% -216.04%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 123.71% -58.27% -118.04% -171.92% -221.42%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -117.33% 50.31% 105.41% 155.04% 201.97%
Return on Equity (ROE)
-15.87% 18.94% -12.21% -16.80% 4.82% -11.90% 12.65% -7.55% -19.19% -35.41% -14.07%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -87.69% -59.54% -54.01% -243.68% -127.33%
Operating Return on Assets (OROA)
-13.34% 13.86% -10.54% -16.44% 2.18% -11.15% 13.18% -8.57% -14.66% -24.02% -9.33%
Return on Assets (ROA)
-12.81% 14.20% -9.40% -14.56% 4.31% -10.10% 13.32% -7.97% -14.72% -24.68% -10.08%
Return on Common Equity (ROCE)
-15.87% 18.94% -12.21% -16.80% 4.82% -11.90% 12.65% -7.55% -19.18% -35.49% -14.11%
Return on Equity Simple (ROE_SIMPLE)
-10.83% 14.37% -12.16% -13.50% 4.53% -12.11% 11.27% -7.59% -20.14% -34.91% 0.00%
Net Operating Profit after Tax (NOPAT)
-13 43 -30 -56 14 -54 44 -58 -93 -125 -124
NOPAT Margin
-46.24% 39.53% -65.34% -136.83% 8.72% -43.81% 15.91% -35.08% -53.06% -113.03% -98.95%
Net Nonoperating Expense Percent (NNEP)
-3.84% 0.68% -2.16% -3.32% 2.33% -2.58% 6.28% 0.40% -6.55% -18.53% 5.38%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - 5.97% -7.94% -10.88% -14.91% -16.45%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
43.08% 12.02% 37.88% 55.35% 15.50% 24.20% 14.12% 28.85% 30.57% 55.40% 50.68%
R&D to Revenue
122.97% 47.58% 155.35% 240.13% 75.68% 138.39% 69.97% 121.26% 145.23% 206.06% 190.67%
Operating Expenses to Revenue
166.05% 59.60% 193.23% 295.48% 91.18% 162.59% 84.09% 150.11% 175.80% 261.47% 241.35%
Earnings before Interest and Taxes (EBIT)
-18 44 -43 -79 14 -77 82 -59 -133 -230 -85
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-16 48 -38 -77 14 -71 92 -50 -135 -234 -78
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.64 3.45 3.25 3.90 3.29 4.38 3.20 2.14 1.95 2.37 1.72
Price to Tangible Book Value (P/TBV)
3.88 3.57 3.37 3.99 3.37 4.50 3.27 2.20 2.01 2.44 1.74
Price to Revenue (P/Rev)
21.32 9.93 22.28 50.08 12.45 20.43 8.53 9.48 7.40 14.55 8.71
Price to Earnings (P/E)
0.00 24.00 0.00 0.00 67.25 0.00 28.39 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 4.17% 0.00% 0.00% 1.49% 0.00% 3.52% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 20.34 9.28 14.10 12.21 15.30
Enterprise Value to Revenue (EV/Rev)
14.35 6.23 14.42 37.02 8.61 15.51 7.31 5.67 3.89 9.17 3.90
Enterprise Value to EBITDA (EV/EBITDA)
0.00 14.29 0.00 0.00 99.62 0.00 21.77 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 15.42 0.00 0.00 99.45 0.00 24.60 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 15.76 0.00 0.00 98.74 0.00 45.97 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
14.94 7.13 0.00 0.00 20.96 0.00 0.00 38.13 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
17.56 6.68 0.00 0.00 103.92 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.29 0.24 0.19
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.17 0.12
Financial Leverage
-1.12 -1.25 -1.22 -1.07 -1.02 -1.03 -0.95 -0.86 -0.89 -0.90 -0.91
Leverage Ratio
1.24 1.33 1.30 1.15 1.12 1.18 0.95 0.95 1.30 1.43 1.40
Compound Leverage Factor
1.19 1.40 1.17 1.02 2.24 1.07 0.96 0.87 1.17 1.46 1.47
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 22.25% 19.53% 15.85%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.25% 5.78% 5.73%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 19.00% 13.75% 10.13%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% -0.43% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 77.71% 80.90% 84.15%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.40 -0.70 -1.53
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.55 2.52 7.72
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.20 -0.49 -0.98
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.05 -1.31 -0.96
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.63 4.73 4.86
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.75 -0.92 -0.62
Altman Z-Score
6.37 5.58 7.71 21.54 15.75 11.47 14.51 8.15 2.30 2.37 1.97
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02% -0.24% -0.27%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.25 1.33 3.18 5.86 8.39 5.27 6.00 10.58 8.60 6.61 6.25
Quick Ratio
2.22 1.31 3.10 5.66 8.28 5.08 5.66 10.21 8.35 6.39 6.02
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
23 102 -73 -94 13 -30 -87 -59 -40 -160 -73
Operating Cash Flow to CapEx
1,388.13% 6,319.71% -632.59% -1,107.26% 875.48% -47.49% -126.91% 63.61% -422.43% -3,316.19% -4,289.43%
Free Cash Flow to Firm to Interest Expense
1,745.65 4,844.12 0.00 0.00 0.00 0.00 -6,673.38 0.00 0.00 -33.90 -2.29
Operating Cash Flow to Interest Expense
2,051.23 4,535.14 0.00 0.00 0.00 0.00 -1,296.38 0.00 0.00 -42.90 -4.23
Operating Cash Flow Less CapEx to Interest Expense
1,903.46 4,463.38 0.00 0.00 0.00 0.00 -2,317.92 0.00 0.00 -44.19 -4.33
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.20 0.34 0.11 0.08 0.25 0.18 0.44 0.24 0.19 0.12 0.14
Accounts Receivable Turnover
18.45 25.18 9.47 7.17 9.87 7.43 7.07 3.45 6.62 2.61 2.79
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
17.30 40.27 9.07 4.30 11.35 6.55 11.02 3.77 2.79 1.75 2.22
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
19.79 14.50 38.55 50.92 36.99 49.11 51.63 105.77 55.12 139.71 131.01
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
19.79 14.50 38.55 50.92 36.99 49.11 51.63 105.77 55.12 139.71 131.01
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-31 -90 -47 -8.79 -8.11 -32 99 101 48 83 32
Invested Capital Turnover
-2.12 -1.81 -0.68 -1.46 -18.55 -6.18 8.17 1.65 2.35 1.69 2.18
Increase / (Decrease) in Invested Capital
-36 -59 43 38 0.68 -23 131 1.68 -52 35 -51
Enterprise Value (EV)
398 679 666 1,503 1,349 1,903 2,012 934 679 1,014 490
Market Capitalization
592 1,083 1,029 2,033 1,951 2,507 2,346 1,560 1,292 1,608 1,093
Book Value per Share
$4.01 $7.63 $6.74 $9.28 $10.46 $9.96 $12.54 $12.14 $10.87 $9.68 $8.90
Tangible Book Value per Share
$3.77 $7.38 $6.50 $9.06 $10.20 $9.69 $12.26 $11.83 $10.56 $9.42 $8.78
Total Capital
162 314 316 522 593 572 734 727 852 838 755
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 189 164 120
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 162 115 76
Net Debt
-193 -403 -363 -530 -601 -604 -334 -627 -614 -591 -604
Capital Expenditures (CapEx)
1.92 1.51 5.31 7.20 7.35 11 13 38 18 6.10 3.15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-42 -95 -66 -32 -38 -86 20 -12 -4.33 41 -0.55
Debt-free Net Working Capital (DFNWC)
54 35 158 262 492 517 354 611 589 539 547
Net Working Capital (NWC)
54 35 158 262 492 517 354 611 562 490 504
Net Nonoperating Expense (NNE)
4.76 -2.03 8.30 15 -13 16 -39 -2.55 41 112 -32
Net Nonoperating Obligations (NNO)
-193 -403 -363 -530 -601 -604 -635 -627 -614 -591 -604
Total Depreciation and Amortization (D&A)
2.21 3.50 4.88 2.86 -0.02 5.52 11 8.93 -2.14 -3.94 7.03
Debt-free, Cash-free Net Working Capital to Revenue
-151.95% -86.93% -142.65% -80.01% -24.21% -70.41% 7.10% -7.03% -2.48% 36.96% -0.44%
Debt-free Net Working Capital to Revenue
195.40% 32.44% 342.49% 644.96% 313.88% 421.06% 128.54% 371.55% 337.54% 487.47% 435.74%
Net Working Capital to Revenue
195.40% 32.44% 342.49% 644.96% 313.88% 421.06% 128.54% 371.55% 321.67% 443.62% 401.28%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.45) $0.57 ($1.05) ($1.31) $0.48 ($1.21) $1.42 ($0.93) $0.00 ($3.58) ($1.24)
Adjusted Weighted Average Basic Shares Outstanding
39.02M 41.27M 46.82M 53.94M 56.53M 57.21M 58.38M 59.65M 0.00 65.04M 74.24M
Adjusted Diluted Earnings per Share
($0.45) $0.56 ($1.05) ($1.31) $0.46 ($1.21) $1.37 ($0.93) $0.00 ($3.58) ($1.24)
Adjusted Weighted Average Diluted Shares Outstanding
39.02M 42.39M 46.82M 53.94M 58.47M 57.21M 60.50M 59.65M 0.00 65.04M 74.24M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
40.58M 46.57M 47.01M 56.29M 56.94M 57.95M 59.38M 60.03M 0.00 70.46M 73.34M
Normalized Net Operating Profit after Tax (NOPAT)
-13 43 -30 -56 14 -54 31 -58 -93 -125 -124
Normalized NOPAT Margin
-46.24% 39.53% -65.34% -136.83% 8.72% -43.81% 11.14% -35.08% -53.06% -113.03% -98.95%
Pre Tax Income Margin
-63.37% 42.30% -84.31% -173.41% 17.35% -56.51% 30.04% -33.12% -68.51% -212.61% -71.38%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-1,409.46 2,097.43 0.00 0.00 0.00 0.00 6,290.92 0.00 0.00 -48.85 -2.67
NOPAT to Interest Expense
-987.43 2,052.08 0.00 0.00 0.00 0.00 3,366.69 0.00 0.00 -26.50 -3.89
EBIT Less CapEx to Interest Expense
-1,557.23 2,025.67 0.00 0.00 0.00 0.00 5,269.38 0.00 0.00 -50.14 -2.77
NOPAT Less CapEx to Interest Expense
-1,135.20 1,980.31 0.00 0.00 0.00 0.00 2,345.15 0.00 0.00 -27.79 -3.99
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-43.78% 16.13% 0.00% -20.94% 0.00% 0.00% 0.00% 0.00% 0.00% -5.11% 0.00%

Quarterly Metrics And Ratios for Xencor

This table displays calculated financial ratios and metrics derived from Xencor's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - 70,461,934.00 71,170,754.00 71,323,046.00 71,410,469.00 73,338,642.00 74,141,596.00 74,353,397.00
DEI Adjusted Shares Outstanding
- - - - 70,461,934.00 71,170,754.00 71,323,046.00 71,410,469.00 73,338,642.00 74,141,596.00 74,353,397.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - -0.69 -0.43 -0.08 -0.09 -1.76 -0.29 0.53
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-15.64% -47.48% -69.92% 3.58% 104.61% 82.41% 18.00% -46.51% -86.20% 17.46% 454.88%
EBITDA Growth
-19.79% -168.81% -54.50% -167.27% 39.41% 61.17% 91.71% 97.84% -172.61% 36.79% 1,128.59%
EBIT Growth
-14.66% -161.22% -56.92% -212.02% 35.42% 55.23% 89.34% 92.94% -174.50% 35.62% 885.27%
NOPAT Growth
10.01% -112.99% -202.12% 51.82% 21.00% 40.09% 13.91% -306.95% -80.31% -11.74% 169.04%
Net Income Growth
-21.98% -213.30% -95.48% -75.60% 34.38% 55.18% 87.30% 85.60% -165.08% 29.51% 754.32%
EPS Growth
-17.65% -194.59% -80.00% -39.02% 45.00% 62.39% 88.89% 84.21% -159.09% 29.27% 725.00%
Operating Cash Flow Growth
-85.73% -80.50% -16.40% -374.30% 71.47% 46.00% -9.51% -3.76% -316.94% -53.04% 108.57%
Free Cash Flow Firm Growth
269.65% -650.38% 126.22% -232.35% -523.95% 72.46% -588.59% 130.56% 22.91% 38.25% 77.09%
Invested Capital Growth
-47.59% 12.83% -49.39% 72.52% 2.97% -14.43% -11.48% -61.46% -57.93% -29.41% 73.02%
Revenue Q/Q Growth
-64.20% 86.70% 4.93% 196.66% -38.00% 33.23% -51.85% 34.47% -84.01% 1,034.21% 127.48%
EBITDA Q/Q Growth
-234.27% 12.89% 38.62% 5.89% -6.73% 42.47% 85.21% 77.92% -14,409.26% 86.66% 340.72%
EBIT Q/Q Growth
-257.66% 11.81% 38.01% 4.06% -6.92% 36.19% 83.71% 36.49% -4,057.94% 85.03% 298.68%
NOPAT Q/Q Growth
-62.54% 4.30% 11.43% 76.13% -227.69% 23.18% -43.25% -12.86% -45.19% 52.39% 188.51%
Net Income Q/Q Growth
-284.74% -0.11% 29.62% 2.62% -5.26% 36.62% 80.45% -10.39% -1,837.71% 83.14% 281.49%
EPS Q/Q Growth
-313.79% 1.80% 32.71% 20.83% -15.79% 37.88% 80.49% -12.50% -1,800.00% 83.04% 272.41%
Operating Cash Flow Q/Q Growth
-131.38% -24.78% 51.40% -56.94% 67.45% -124.22% 15.27% -67.80% -30.78% 17.70% 104.75%
Free Cash Flow Firm Q/Q Growth
-96.07% -129.78% -93.95% -868.73% 28.11% 59.29% -117.18% 148.08% -281.37% 67.40% 19.43%
Invested Capital Q/Q Growth
144.45% 170.13% 160.42% 82.59% -37.52% 17.81% -34.13% -20.50% -31.80% 97.65% 61.45%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-472.30% -286.92% -260.54% -82.65% -142.28% -61.43% -18.87% -3.10% -2,811.25% -33.06% 34.98%
Operating Margin
-341.71% -231.61% -310.17% -24.96% -131.93% -76.07% -226.29% -189.92% -1,724.14% -72.37% 19.62%
EBIT Margin
-456.26% -281.01% -258.22% -83.51% -144.01% -68.98% -23.33% -11.02% -2,865.26% -37.81% 33.02%
Profit (Net Income) Margin
-463.31% -287.71% -266.59% -87.51% -148.58% -70.69% -28.70% -23.56% -2,854.65% -42.42% 33.84%
Tax Burden Percent
100.00% 100.00% 100.00% 103.63% 100.76% 99.20% 100.00% 155.95% 100.22% 99.13% 100.45%
Interest Burden Percent
101.55% 102.38% 103.24% 101.12% 102.39% 103.31% 123.00% 137.08% 99.41% 113.18% 102.03%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.45%
Return on Invested Capital (ROIC)
-540.02% -338.34% -296.03% -29.44% -229.82% -118.07% -554.85% -290.28% -3,188.87% -102.02% 71.92%
ROIC Less NNEP Spread (ROIC-NNEP)
-533.72% -332.84% -294.61% -23.31% -226.59% -116.60% -559.23% -295.45% -3,175.11% -102.85% 68.86%
Return on Net Nonoperating Assets (RNNOA)
472.79% 296.32% 265.61% 21.02% 207.90% 103.38% 523.22% 269.50% 2,972.61% 93.31% -62.48%
Return on Equity (ROE)
-67.23% -42.02% -30.42% -8.42% -21.93% -14.69% -31.64% -20.78% -216.26% -8.71% 9.44%
Cash Return on Invested Capital (CROIC)
-64.22% -183.67% -150.64% -243.68% -231.49% -137.34% -211.66% -127.33% -321.53% -255.70% -239.10%
Operating Return on Assets (OROA)
-88.75% -48.80% -26.79% -9.63% -20.34% -11.78% -3.75% -1.51% -339.88% -4.95% 8.08%
Return on Assets (ROA)
-90.13% -49.97% -27.66% -10.09% -20.99% -12.08% -4.61% -3.24% -338.62% -5.55% 8.28%
Return on Common Equity (ROCE)
-67.25% -42.08% -30.48% -8.45% -21.93% -14.71% -31.71% -20.84% -216.26% -8.71% 9.44%
Return on Equity Simple (ROE_SIMPLE)
-23.26% -32.88% -28.61% 0.00% -32.98% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-38 -39 -39 -9.22 -30 -23 -33 -38 -55 -26 23
NOPAT Margin
-239.20% -162.12% -217.12% -17.47% -92.35% -53.25% -158.40% -132.94% -1,206.90% -50.66% 19.71%
Net Nonoperating Expense Percent (NNEP)
-6.31% -5.49% -1.42% -6.14% -3.24% -1.47% 4.37% 5.17% -13.76% 0.83% 3.06%
Return On Investment Capital (ROIC_SIMPLE)
-4.88% -5.32% -4.40% -1.10% -3.81% -3.03% -4.39% -4.97% -8.73% -4.27% 3.50%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
86.18% 74.23% 82.98% 28.25% 52.97% 34.66% 67.39% 60.35% 392.14% 31.99% 8.03%
R&D to Revenue
355.52% 257.38% 327.19% 96.71% 178.96% 141.41% 258.90% 229.57% 1,432.00% 140.38% 72.35%
Operating Expenses to Revenue
441.71% 331.61% 410.17% 124.96% 231.93% 176.07% 326.29% 289.92% 1,824.14% 172.37% 80.38%
Earnings before Interest and Taxes (EBIT)
-73 -67 -46 -44 -47 -30 -4.90 -3.11 -129 -19 38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-76 -69 -46 -44 -47 -27 -3.96 -0.88 -127 -17 41
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.25 2.12 1.75 2.37 1.17 0.90 1.34 1.72 1.72 2.37 3.31
Price to Tangible Book Value (P/TBV)
2.33 2.20 1.80 2.44 1.20 0.92 1.36 1.74 1.74 2.40 3.34
Price to Revenue (P/Rev)
8.18 8.30 13.48 14.55 5.89 3.81 5.57 8.71 9.08 11.37 9.25
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
15.94 9.64 12.76 12.21 3.12 0.00 6.25 15.30 17.90 17.01 19.64
Enterprise Value to Revenue (EV/Rev)
4.86 4.90 6.29 9.17 1.27 0.00 1.68 3.90 4.01 6.99 6.82
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
13.64 23.16 20.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.31 0.33 0.24 0.24 0.24 0.23 0.21 0.19 0.21 0.21 0.17
Long-Term Debt to Equity
0.25 0.26 0.18 0.17 0.16 0.15 0.14 0.12 0.16 0.15 0.13
Financial Leverage
-0.89 -0.89 -0.90 -0.90 -0.92 -0.89 -0.94 -0.91 -0.94 -0.91 -0.91
Leverage Ratio
1.32 1.32 1.29 1.43 1.45 1.47 1.40 1.40 1.42 1.43 1.38
Compound Leverage Factor
1.35 1.35 1.34 1.45 1.49 1.52 1.73 1.91 1.41 1.62 1.41
Debt to Total Capital
23.58% 24.68% 19.66% 19.53% 19.44% 18.95% 17.55% 15.85% 17.39% 17.25% 14.50%
Short-Term Debt to Total Capital
4.36% 5.34% 5.06% 5.78% 6.62% 6.57% 5.98% 5.73% 4.23% 4.50% 3.53%
Long-Term Debt to Total Capital
19.23% 19.33% 14.61% 13.75% 12.82% 12.38% 11.57% 10.13% 13.16% 12.75% 10.97%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-0.04% -0.24% -0.33% -0.43% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
76.46% 75.57% 80.67% 80.90% 80.56% 81.05% 82.45% 84.15% 82.61% 82.75% 85.50%
Debt to EBITDA
-1.20 -0.90 -0.77 -0.70 -0.76 -0.90 -1.13 -1.53 -0.68 -0.71 -0.91
Net Debt to EBITDA
3.57 2.39 2.96 2.52 2.88 3.46 4.97 7.72 3.11 3.09 4.69
Long-Term Debt to EBITDA
-0.98 -0.70 -0.57 -0.49 -0.50 -0.59 -0.75 -0.98 -0.52 -0.52 -0.69
Debt to NOPAT
-1.99 -1.56 -1.18 -1.31 -1.32 -1.43 -1.39 -0.96 -0.73 -0.69 -0.93
Net Debt to NOPAT
5.92 4.13 4.51 4.73 5.03 5.52 6.10 4.86 3.32 3.04 4.78
Long-Term Debt to NOPAT
-1.63 -1.22 -0.88 -0.92 -0.87 -0.94 -0.91 -0.62 -0.55 -0.51 -0.71
Altman Z-Score
2.47 1.99 2.16 3.02 1.08 0.67 1.54 2.28 0.86 2.19 4.73
Noncontrolling Interest Sharing Ratio
-0.03% -0.15% -0.21% -0.24% -0.03% -0.15% -0.22% -0.27% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
8.09 7.53 6.49 6.61 5.89 5.34 5.99 6.25 6.57 6.39 6.54
Quick Ratio
7.85 7.20 6.26 6.39 5.74 5.11 5.70 6.02 6.22 6.09 6.16
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
7.48 -47 5.74 -44 -32 -13 -28 13 -24 -7.97 -6.42
Operating Cash Flow to CapEx
-43,075.00% -2,278.62% -2,490.67% -2,995.01% -1,123.27% -9,495.82% -16,839.89% -4,536.05% -11,086.56% -10,345.35% 146.45%
Free Cash Flow to Firm to Interest Expense
0.77 -5.05 0.64 0.00 -3.66 -1.57 -3.66 1.83 -5.20 -1.08 -1.56
Operating Cash Flow to Interest Expense
-5.88 -7.43 -3.52 0.00 -1.87 -4.41 -4.02 -7.03 -14.39 -7.57 0.64
Operating Cash Flow Less CapEx to Interest Expense
-5.89 -7.75 -3.66 0.00 -2.04 -4.46 -4.04 -7.19 -14.52 -7.64 0.20
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.19 0.17 0.10 0.12 0.14 0.17 0.16 0.14 0.12 0.13 0.24
Accounts Receivable Turnover
7.87 5.03 2.28 2.61 4.24 3.52 6.30 2.79 3.91 2.34 4.63
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
2.54 2.13 1.41 1.75 2.08 2.44 2.57 2.22 1.77 1.97 3.84
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
46.40 72.63 159.99 139.71 86.02 103.69 57.96 131.01 93.32 156.10 78.87
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
46.40 72.63 159.99 139.71 86.02 103.69 57.96 131.01 93.32 156.10 78.87
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
50 71 45 83 52 61 40 32 22 43 70
Invested Capital Turnover
2.26 2.09 1.36 1.69 2.49 2.22 3.50 2.18 2.64 2.01 3.65
Increase / (Decrease) in Invested Capital
-46 8.12 -44 35 1.50 -10 -5.22 -51 -30 -18 29
Enterprise Value (EV)
803 688 580 1,014 162 0.16 252 490 391 734 1,368
Market Capitalization
1,353 1,167 1,243 1,608 750 559 837 1,093 884 1,194 1,855
Book Value per Share
$9.82 $8.93 $11.46 $9.68 $9.08 $8.72 $8.77 $8.90 $7.03 $6.79 $7.54
Tangible Book Value per Share
$9.51 $8.62 $11.17 $9.42 $8.89 $8.56 $8.63 $8.78 $6.93 $6.70 $7.47
Total Capital
785 728 879 838 794 765 758 755 624 608 655
Total Debt
185 180 173 164 154 145 133 120 109 105 95
Total Long-Term Debt
151 141 128 115 102 95 88 76 82 78 72
Net Debt
-549 -477 -660 -591 -588 -559 -585 -604 -494 -460 -488
Capital Expenditures (CapEx)
0.13 3.03 1.28 1.66 1.44 0.38 0.18 1.14 0.61 0.54 1.80
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2.04 24 0.26 41 16 23 6.27 -0.55 -9.14 12 40
Debt-free Net Working Capital (DFNWC)
538 532 543 539 485 467 477 547 436 469 446
Net Working Capital (NWC)
504 493 499 490 433 417 432 504 409 441 422
Net Nonoperating Expense (NNE)
36 30 8.80 37 18 7.60 -27 -31 74 -4.22 -16
Net Nonoperating Obligations (NNO)
-549 -477 -660 -591 -588 -559 -585 -604 -494 -460 -491
Total Depreciation and Amortization (D&A)
-2.57 -1.41 -0.41 0.45 0.57 3.29 0.94 2.24 2.44 2.43 2.29
Debt-free, Cash-free Net Working Capital to Revenue
1.23% 16.97% 0.28% 36.96% 12.43% 15.99% 4.18% -0.44% -9.39% 11.67% 20.17%
Debt-free Net Working Capital to Revenue
325.31% 378.66% 588.88% 487.47% 381.50% 318.08% 317.93% 435.74% 447.63% 446.50% 222.21%
Net Working Capital to Revenue
304.63% 350.97% 540.69% 443.62% 340.20% 283.86% 287.72% 401.28% 420.50% 420.44% 210.68%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.20) ($1.09) ($0.72) ($0.57) ($0.66) ($0.41) ($0.08) ($0.09) ($1.71) ($0.29) $0.52
Adjusted Weighted Average Basic Shares Outstanding
61.21M 61.68M 64.02M 65.04M 73.67M 74.28M 74.41M 74.24M 75.25M 75.86M 76.22M
Adjusted Diluted Earnings per Share
($1.20) ($1.09) ($0.72) ($0.57) ($0.66) ($0.41) ($0.08) ($0.09) ($1.71) ($0.29) $0.50
Adjusted Weighted Average Diluted Shares Outstanding
61.21M 61.68M 64.02M 65.04M 73.67M 74.28M 74.41M 74.24M 75.25M 75.86M 78.35M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
61.66M 61.83M 69.98M 70.46M 71.17M 71.32M 71.41M 73.34M 74.14M 74.35M 75.04M
Normalized Net Operating Profit after Tax (NOPAT)
-38 -39 -39 -9.22 -30 -23 -33 -38 -55 -26 16
Normalized NOPAT Margin
-239.20% -162.12% -217.12% -17.47% -92.35% -53.25% -158.40% -132.94% -1,206.90% -50.66% 13.74%
Pre Tax Income Margin
-463.31% -287.71% -266.59% -84.45% -147.46% -71.26% -28.70% -15.11% -2,848.45% -42.79% 33.69%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-7.54 -7.24 -5.09 0.00 -5.44 -3.65 -0.64 -0.42 -27.53 -2.63 9.35
NOPAT to Interest Expense
-3.95 -4.18 -4.28 0.00 -3.49 -2.82 -4.34 -5.10 -11.60 -3.53 5.58
EBIT Less CapEx to Interest Expense
-7.56 -7.56 -5.23 0.00 -5.61 -3.70 -0.66 -0.58 -27.66 -2.71 8.91
NOPAT Less CapEx to Interest Expense
-3.97 -4.50 -4.42 0.00 -3.66 -2.86 -4.36 -5.26 -11.73 -3.60 5.14
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% -5.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Xencor’s Q2 2026 results show improving revenue and a smaller net loss, but the company remains dependent on its investment portfolio to fund ongoing operations. Revenue increased to $51.2 million from $4.5 million in Q1 2026 and $43.6 million in Q2 2025. The quarterly net loss narrowed substantially to $21.7 million, compared with a $128.9 million loss in Q1 and a $30.8 million loss in the prior-year quarter. However, operating expenses rose to $88.3 million, including $71.9 million in research and development spending, leaving Xencor with a $37.1 million operating loss.

The balance sheet remains relatively strong in terms of liquidity. At June 30, 2026, Xencor held $44.7 million in cash, $411.8 million in short-term investments and $108.5 million in long-term investments. These liquid and investment assets totaled approximately $565 million, compared with $221.7 million of total liabilities. The company’s current assets of $523.2 million were more than six times its current liabilities of $81.9 million. Still, total assets declined from $879.4 million in Q2 2025 to $725.0 million, while total equity fell to $503.2 million from $620.4 million over the same period.

Cash flow continues to be a key concern. Xencor generated negative operating cash flow in each of the supplied recent quarters, including -$55.7 million in Q2 2026 and -$67.6 million in Q1 2026. The $20.7 million increase in cash during Q2 was primarily supported by $85.1 million of investment sales or maturities, rather than by business operations. Retained earnings have deteriorated to a deficit of $946.6 million, and the weighted-average share count rose to 75.9 million from 74.3 million a year earlier, indicating modest shareholder dilution.

  • Revenue rebounded: Q2 2026 revenue of $51.2 million increased approximately 17% from $43.6 million in Q2 2025 and was substantially higher than Q1 2026.
  • Losses narrowed: The Q2 net loss improved to $21.7 million from $128.9 million in Q1 2026 and $30.8 million in the year-ago quarter.
  • Strong liquidity: Cash, short-term investments and long-term investments totaled approximately $565 million at the end of Q2 2026, providing a sizable financial cushion.
  • Manageable near-term obligations: Current assets of $523.2 million significantly exceeded current liabilities of $81.9 million, supporting near-term financial flexibility.
  • Investment portfolio remains central to funding: Q2 investing cash flow was positive $85.1 million because of investment maturities or sales, but this is not the same as recurring operating cash generation.
  • Revenue remains volatile: Quarterly revenue has fluctuated sharply, ranging from $4.5 million in Q1 2026 to $51.2 million in Q2 2026, making short-term performance difficult to predict.
  • Persistent operating losses: Xencor reported a $37.1 million operating loss in Q2 2026, as research and development and selling, general and administrative expenses continued to exceed revenue.
  • Ongoing cash burn: Operating cash flow was negative $55.7 million in Q2 2026 and has remained negative across the recent quarters provided, increasing reliance on investments and external financing.
  • Equity base is shrinking: Total equity declined to $503.2 million from $620.4 million in Q2 2025, while retained earnings reached a deficit of $946.6 million.
  • Share dilution: Weighted-average basic shares outstanding increased to 75.9 million from 74.3 million year over year, which can reduce existing shareholders’ proportional ownership and earnings potential.
11/17/26 07:52 PM ETAI Generated. May Contain Errors.

Xencor Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Xencor's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Xencor's net income appears to be on a downward trend, with a most recent value of -$92.14 million in 2025, falling from -$17.59 million in 2015. The previous period was -$236.54 million in 2024. Check out Xencor's forecast to explore projected trends and price targets.

Xencor's total operating income in 2025 was -$177.50 million, based on the following breakdown:
  • Total Gross Profit: $125.58 million
  • Total Operating Expenses: $303.08 million

Over the last 10 years, Xencor's total revenue changed from $27.76 million in 2015 to $125.58 million in 2025, a change of 352.3%.

In the past 13 quarters, Xencor's cash and equivalents has ranged from $14.17 million in Q1 2026 to $59.62 million in Q3 2026, and is currently $59.62 million as of their latest financial filing in Q3 2026.

Xencor had total debt of $119.75 million at the end of 2025, a 26.8% decrease from 2024, and none in 2015.

Over the last 10 years, Xencor's book value per share changed from 4.01 in 2015 to 8.90 in 2025, a change of 121.8%.



Financial statements for NASDAQ:XNCR last updated on 11/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners